3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Ventricular Dysfunction
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Essential Hypertension
1
Cardiotoxicity
1
Breast Neoplasms
1
Interventions
Dexamethasone
169
Bortezomib
92
Lenalidomide
85
daratumumab
44
Thalidomide
44
pomalidomide
43
Melphalan
40
Cyclophosphamide
33
carfilzomib
29
Calcium Dobesilate
27
Prednisone
19
Doxorubicin
16
elotuzumab
14
isatuximab
12
Filgrastim
12
ixazomib
11
Vincristine
10
Peripheral Blood Stem Cell Transplantation
10
belantamab mafodotin
9
Granulocyte Colony-Stimulating Factor
9
Zoledronic Acid
8
selinexor
7
dexamethasone acetate
7
Epoetin Alfa
7
Etoposide
6
fludarabine
5
Cisplatin
5
Carmustine
5
iberdomide
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Multiple Myeloma
×
Enalapril
×
Clear all
NCT01110824
2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3
Completed
90 enrolled